4//SEC Filing
Mond James 4
Accession 0001193805-20-000285
CIK 0001368514other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:07 PM ET
Size
7.8 KB
Accession
0001193805-20-000285
Insider Transaction Report
Form 4
Mond James
CSO/CMO
Transactions
- Award
Common Stock
2020-02-28+40,000→ 62,174 total - Award
Employee Stock Option (right to buy)
2020-02-28+100,000→ 100,000 totalExercise: $2.92Exp: 2030-02-28→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]These shares represent restricted stock units ("RSUs"), which will vest quarterly on the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting.
- [F2]Includes (i) 40,000 RSUs granted on February 28, 2020 and reported on this Form 4, subject to vesting as set forth in footnote (1) and will be settled into common stock upon vesting; and (ii) 22,174 shares of common stock owned by the reporting person.
- [F3]The options vest over four years with 25% of the shares of Common Stock underlying the options vesting on the one year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 28, 2024.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0001554537
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:07 PM ET
- Size
- 7.8 KB